Contact Information
Company Information
Company
Engimmune Therapeutics
Professional Summary
Lars Nieba serves as CEO at Engimmune Therapeutics. Engimmune Therapeutics operates in the biotechnology sector with approximately 27.0 employees. The company is headquartered in Reinach, Basel-Landschaft. To date, Engimmune Therapeutics has raised 16700000.0 in total funding, with the most recent round being Seed.
Industry & Role Insights
-
•
MessageCEO tracks 381 executives in the biotechnology sector.
-
•
34 executive contacts are available in Basel-Landschaft.
-
•
Our database includes 201,468 c suite-level executives.
Technologies
Gmail
Google Apps
Microsoft Office 365
Google Cloud Hosting
Mobile Friendly
Wix
Varnish
Render
Basis
AI
Keywords
immunotherapy
t cell therapy
oncology
machine learning
biotechnology
immunology
precision immunotherapy
soluble t-cell receptors
tcr drugs
cancer treatment
solid tumours
targeted therapy
immune-mediated diseases
ai-guided protein engineering
multi-specific tcrs
high target affinity
enhanced stability
immune responses
biotherapeutics development
clinical candidate selection
tcr-t cell therapies
tumour antigens
high-affinity binding
intracellular antigens
sustained immune responses
biodistribution
effector immune cells
specificity-guided maturation
trispecific tcrs
networking & alliances
therapeutic candidates
autoantigen recognition
novel therapeutic platforms
soluble tcr therapies
preclinical development
pipeline programs
molecular design
oncology indication
inflammatory diseases
bioengineering
cancer immunotherapy
safety profiles
drug development
biological drugs
targeted treatments
clinical studies
healthcare innovation
therapeutic potential
disease management
patient-centric therapies
high-throughput screening
tissue-targeted therapy
receptor engagement
immune system modulation
receptor co-stimulation
hospital & health care
artificial intelligence
information technology & services
Related Executives
Outreach Guidance — biotechnology Sector
Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Lars Nieba, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.
Lars Nieba's Position in the MessageCEO Database
- •Lars Nieba is 1 of 1 verified executive contact we track at Engimmune Therapeutics.
- •365 verified executive contacts in biotechnology are in the MessageCEO database.
- •34 verified executive contacts in Basel-Landschaft are in the database.
- •9 verified contacts work at biotechnology companies in the 27.0 employee range (same size as Engimmune Therapeutics).
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.
Frequently Asked Questions
How do I reach Lars Nieba directly?
Lars Nieba's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Engimmune Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.
What company does Lars Nieba work for?
Lars Nieba is CEO at Engimmune Therapeutics, a company in the biotechnology sector with 27.0 employees. The company is based in Reinach, Basel-Landschaft.
Can I pitch or sell to Lars Nieba?
As CEO at Engimmune Therapeutics, Lars Nieba is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Lars Nieba directly — ideal for B2B sales, partnerships, and executive recruiting.
What industry is Lars Nieba in?
Lars Nieba works in the biotechnology industry as CEO at Engimmune Therapeutics. MessageCEO provides verified contact information for executives across all major industries.
Is Lars Nieba's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Lars Nieba's profile is kept up-to-date with the latest available information.
Last updated: July 26, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans